Salsalate in Patients Mild to Moderate Alzheimer's Disease
Status:
Active, not recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is to test the safety and tolerability of twice daily Salsalate in
patients with mild to moderate Alzheimer's Disease. Half of the participants will receive
Salsalate and half will receive placebo during the 1-year duration of the study.